NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neurala Biosciences

Neurala Biosciences

Private
Carlton, VictoriaFrontier & Industrial Techhttps://www.neurala.co/

Last Round

VC Round

Jun 24, 2021

Est. Valuation

$333,000

Total Funding Raised

$16.22M

Company Overview

Neurala Biosciences is a biotechnology company that develops second-generation psychedelic neuromedicines for mental health and addiction.

Sector

Frontier & Industrial Tech

Verticals

Computer Vision, Smart Manufacturing, Quality Management, Edge Computing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

vision AIvisual inspectionquality control automationmanufacturing AIdefect detectionedge AIindustrial AImachine visioncontinual learning AIcomputer visionsmart manufacturingembedded AIL-DNNlifelong deep neural network

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurala Biosciences Comps

Public and private peers based on sector, stage, and business model.

Neurala Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurala Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 24, 2021
VC RoundMay 21, 2020
Series AJan 18, 2017
SeedJun 2, 2016
GrantOct 23, 2015
Seed
Dec 10, 2014

Neurala Biosciences Investors

Notable investors and investment history

Neurala Biosciences investors
InvestorRounds
Robolution CapitalSeed
Friulia S.p.A.VC Round
Pelion Venture PartnersVC Round, Series A
Idinvest PartnersVC Round, Series A
TechstarsSeed, Accelerator
Motorola Solutions Venture CapitalSeries A
Haiyin CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2020

    $3M raised in a VC Round.

Neurala Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurala Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurala Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlton, Victoria
Year Founded2022
Last FundingJun 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.